Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children Aged 2–5 Years in the United States

por McCarty, James M., Cassie, David, Bedell, Lisa, Lock, Michael D., Bennett, Sean
Publicado 2021

Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12–17 Years in the United States

por McCarty, James M., Cassie, David, Bedell, Lisa, Lock, Michael D., Bennett, Sean
Publicado 2021

Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children and Adolescents Aged 6–17 Years

por McCarty, James M., Gierman, Emma C., Bedell, Lisa, Lock, Michael D., Bennett, Sean
Publicado 2020

1159. A Phase 2 Drug-Vaccine Interaction Study of AV7909 and Ciprofloxacin or Doxycycline on Antibiotic Pharmacokinetics

por Akintunde, Gideon, Drobic, Bojan, Bedell, Lisa, Gan, Lu, Kim, Julia, Beah, Marinda, Ghinai, Isaac, Collado, Santiago Barona
Publicado 2023

368. A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Immunogenicity and Safety of AV7909 for Post-exposure Prophylaxis of Anthrax in Healthy Adults

por Akintunde, Gideon, Drobic, Bojan, Bedell, Lisa, Gan, Lu, Kim, Julia, Beah, Marinda, Ghinai, Isaac, Collado, Santiago Barona
Publicado 2023

2888. Safety and Immunogenicity of an Adjuvanted Chikungunya Virus (CHIKV) Virus-like Particle (VLP) Based Vaccine in Two Pivotal Phase 3 Trials, ≥12 Years of Age

por Richardson, Jason S, Anderson, Debbie, Mendy, Jason, Muhammad, Sufia, Tindale, Lauren, Loreth, Tobi, Tredo, Sarah Royalty, Jenkins, Victoria, Ajiboye, Patrick, Bedell, Lisa
Publicado 2023

1110 Identification of Formulations and Vaccine Schedules of a Trivalent Group B Streptococcus Vaccine for Further Development in Non-pregnant and Pregnant Women

por Leroux-Roels, Geert, Maes, Cathy, Willekens, Julie, Boever, Fien De, Rooij, Richard De, Martell, Leah, Bedell, Lisa, Wittke, Frederick, Slobod, Karen, Dull, Peter M
Publicado 2014